Literature DB >> 4055428

Serum concentrations of total T4, T3, reverse T3 and free T4, T3 in moderately obese patients.

P Chomard, G Vernhes, N Autissier, G Debry.   

Abstract

Serum total thyroxine (T4), 3,5,3'-triiodo-L-thyronine (T3), 3,3',5'-triiodo-L-thyronine (reverse T3 or rT3) and free thyroxine (FT4), free 3,5,3'-triiodo-L-thyronine (FT3) concentrations were measured by radioimmunoassay in 52 moderately obese patients and 32 age-matched control subjects with constant body weight and no dietary restriction. The comparisons of iodothyronine concentrations in the obese and control subjects gave the following results: serum T4 and FT4 concentrations were not different in the two samples (mean +/- s.e. T4: 105.8 +/- 3.0 vs 109.4 +/- 4.0 nmol/l, FT4: 10.9 +/- 0.4 vs 10.8 +/- 0.8 pmol/l). A slight but non-significant decrease in serum rT3 concentrations was observed in the obese patients (0.29 +/- 0.02 vs 0.32 +/- 0.02 nmol/l). A slight (10 per cent) but highly significant (P less than 0.01) decrease was observed in the obese patients for serum T3 (2.20 +/- 0.06 vs 2.44 +/- 0.05 nmol/l) and FT3 (6.0 +/- 0.2 vs 6.9 +/- 0.2 pmol/l). Serum FT4 and T4 on the one hand and serum FT3 and T3 on the other were positively correlated both in the obese and control subjects. No correlation was found between serum T3 and weight expressed as body mass index. The results suggest that the most important factor responsible for the decrease in the serum total and free T3 concentrations is the nutrient intake.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4055428

Source DB:  PubMed          Journal:  Hum Nutr Clin Nutr        ISSN: 0263-8290


  8 in total

1.  Plasma concentrations of free triiodothyronine predict weight change in euthyroid persons.

Authors:  Emilio Ortega; Nicola Pannacciulli; Clifton Bogardus; Jonathan Krakoff
Journal:  Am J Clin Nutr       Date:  2007-02       Impact factor: 7.045

2.  Neuroendocrine alterations in obese patients with sleep apnea syndrome.

Authors:  Fabio Lanfranco; Giovanna Motta; Marco Alessandro Minetto; Matteo Baldi; Marcella Balbo; Ezio Ghigo; Emanuela Arvat; Mauro Maccario
Journal:  Int J Endocrinol       Date:  2010-02-23       Impact factor: 3.257

3.  Changes in lifestyle improve body composition, thyroid function, and structure in obese children.

Authors:  G Radetti; S Longhi; M Baiocchi; W Cassar; F Buzi
Journal:  J Endocrinol Invest       Date:  2011-05-27       Impact factor: 4.256

4.  The relationship between hyperthyrotropinemia and metabolic and cardiovascular risk factors in a large group of overweight and obese children and adolescents.

Authors:  G Radetti; G Grugni; F Lupi; N Marazzi; S Longhi; A Fanolla; A Sartorio
Journal:  J Endocrinol Invest       Date:  2017-06-05       Impact factor: 4.256

5.  ATHEROGENIC INDICES IN THE ASSESSMENT OF CARDIOVASCULAR DISEASE RISK IN CHILDREN WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM.

Authors:  N Akici; Z E Onal; T Gürbüz; C Sağ; S Kilinç
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

Review 6.  Thyroid function and obesity.

Authors:  Silvia Longhi; Giorgio Radetti
Journal:  J Clin Res Pediatr Endocrinol       Date:  2012-11-01

7.  Thyroid Antagonists (Perchlorate, Thiocyanate, and Nitrate) and Childhood Growth in a Longitudinal Study of U.S. Girls.

Authors:  Nancy A Mervish; Ashley Pajak; Susan L Teitelbaum; Susan M Pinney; Gayle C Windham; Lawrence H Kushi; Frank M Biro; Liza Valentin-Blasini; Benjamin C Blount; Mary S Wolff
Journal:  Environ Health Perspect       Date:  2015-07-07       Impact factor: 9.031

Review 8.  Hypothyroidism and obesity: An intriguing link.

Authors:  Debmalya Sanyal; Moutusi Raychaudhuri
Journal:  Indian J Endocrinol Metab       Date:  2016 Jul-Aug
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.